North America Interventional Cardiology Peripheral Vascular Devices Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2029 |
 Market Size (Base Year) |
USD 9,596.92 Million |
 Market Size (Forecast Year) |
USD 3.27 Million |
 CAGR |
% |
| Major Markets Players |
|
>北美介入心脏病学和外周血管设备市场，按产品（血管成形术球囊、支架、导管、血管内动脉瘤修复支架移植物、下腔静脉 (IVC) 过滤器、斑块修改设备、配件和血流动力学流量改变设备）、类型（常规和标准）、程序（髂动脉介入、股腘动脉介入、胫骨（膝下）介入、外周血管成形术、动脉血栓切除术和外周动脉粥样硬化切除术）、适应症（外周动脉疾病和冠状动脉介入）、年龄组（老年、成人和儿童）最终用户（医院、门诊手术中心、护理机构、诊所等）、分销渠道（直接招标、第三方分销商等）、国家（美国、加拿大和墨西哥）行业2029 年趋势与预测
市场分析与洞察 ：北美介入心脏病学和外周血管设备市场
北美介入心脏病学和外周血管设备市场预计将在 2022 年至 2029 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2022 年至 2029 年的预测期内，该市场将以 7.7% 的复合年增长率增长，预计将从 2021 年的 95.9692 亿美元达到 2029 年的 166.5103 亿美元。冠状动脉疾病、缺血性心脏病和血管疾病患病率的增加，以及对及时治疗和使用设备的认识的激增，可能是推动预测期内市场需求的主要驱动力。
介入心脏病学是心脏病学和外周血管设备专科内的一个医学领域，它使用增强、常规和先进以及其他诊断技术来评估冠状动脉和心腔的血流和压力，以及技术程序和药物来治疗损害心血管系统功能的异常。介入心脏病学和外周血管设备之所以被使用，是因为这些设备改变了久坐的生活方式。它减少了冠状动脉疾病、缺血性心脏病和血管疾病等慢性心脏病的并发症。
冠心病是女性死亡的主要原因。了解心血管疾病的知识可以培养健康的生活方式。充分了解症状及其风险因素可能有助于减少人口暴露于可改变的风险因素，并有助于预防和控制策略。了解心血管疾病的症状将有助于及时治疗。
推动北美介入性心脏病学和外周血管设备市场增长的因素包括冠状动脉疾病、缺血性心脏病和血管疾病患病率的提高、人们对及时治疗和使用设备的认识的提高、心脏病学和外周血管设备的技术进步、对非侵入性手术的兴趣增加以及有利的报销政策。然而，预计会制约市场的因素包括设备成本的上升、使用设备时观察到的风险、产品召回的增加以及替代疗法的可用性。另一方面，市场参与者的战略举措、医疗保健支出的增加和研发活动的增加以及老年人口的增长可能为北美介入性心脏病学和外周血管设备市场的增长提供机会。对熟练专业知识的需求、医院基础设施的缺乏以及监管部门的批准可能会给北美介入性心脏病学和外周血管设备市场带来挑战。
北美介入心脏病学和外周血管设备市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况，请联系我们获取分析师简报，我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。
北美介入心脏病学和外周血管设备市场范围和市场规模
北美介入心脏病学和外周血管设备市场分为七个部分：产品、类型、程序、适应症、年龄组、最终用户和分销渠道。
- 根据产品，北美介入心脏病学和外周血管设备市场细分为血管成形术球囊、支架、导管、血管内动脉瘤修复支架移植物、下腔静脉 (IVC) 过滤器、斑块改造设备、配件和血流动力学流量改变设备。由于外周动脉疾病病例增加、久坐生活方式风险增加、血管成形术球囊技术进步以及美国医疗保健中存在治疗心脏病的报销政策，预计 2022 年血管成形术球囊细分市场将主导北美介入心脏病学和外周血管设备市场。
- 根据类型，北美介入心脏病学和外周血管设备市场分为常规和标准。由于冠状动脉疾病、颈动脉疾病等心血管疾病的患病率不断上升，以及美国和加拿大医院的医生和心脏病专家对常规介入心脏病学和外周血管设备的可用性和偏好，预计到 2022 年，常规设备将主导北美介入心脏病学和外周血管设备市场。
- 根据手术程序，北美介入心脏病学和外周血管器械市场细分为髂动脉介入、股腘动脉介入、胫骨（膝下）介入、外周血管成形术、动脉血栓切除术和外周动脉粥样硬化切除术。由于过去十年来技术进步，外周血管成形术器械越来越先进，预计 2022 年外周血管成形术领域将主导北美介入心脏病学和外周血管器械市场。
- 根据适应症，北美介入心脏病学和外周血管器械市场细分为外周动脉疾病和冠状动脉介入。由于外周动脉疾病的增加、老年人口的增加以及产品审批的增加，预计 2022 年外周动脉疾病领域将主导北美介入心脏病学和外周血管器械市场。
- 根据年龄组，北美介入心脏病学和外周血管设备市场分为老年人、成人和儿童。预计到 2022 年，老年人群体将主导北美介入心脏病学和外周血管设备市场。老年人更容易受到伤害，因为他们对各种血管疾病的免疫力较弱，并且在美国，老年人可以享受医疗保险等报销政策，以最低成本治疗老年人。
- 根据最终用户，北美介入心脏病学和外周血管设备市场分为医院、门诊手术中心、护理机构、诊所和其他。预计到 2022 年，医院部门将主导北美介入心脏病学和外周血管设备市场，因为冠状动脉疾病和血管疾病等慢性心脏病的发病率上升、手术的增加、先进医院设施的可用性以及医院对慢性心脏病治疗的认识提高将主导市场。
- 根据分销渠道，北美介入心脏病学和外周血管设备市场细分为直接招标、第三方分销商和其他。2022 年，由于客户偏好上升、采购价格低廉以及成本节约减少，第三方分销商部门预计将主导北美介入心脏病学和外周血管设备市场。
北美介入心脏病学和外周血管设备市场国家级分析
对北美介入心脏病学和外周血管设备市场进行了分析，并按产品、类型、程序、适应症、年龄组、最终用户和分销渠道提供了市场规模信息。
北美介入心脏病学和外周血管设备市场报告涵盖的国家包括美国、加拿大和墨西哥。
- 2022 年，美国预计将占据主导地位，因为其拥有最大的消费市场和高 GDP。此外，美国拥有世界上最高的家庭支出，并与多个国家签订了贸易协定，使其成为消费品的最大市场，患者人数不断增加，主要市场参与者的存在以及该地区技术进步的不断加快。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了北美品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。
新兴经济体介入心脏病学和外周血管设备的增长潜力以及市场参与者的战略举措正在为北美介入心脏病学和外周血管设备市场创造新的机遇
北美介入心脏病学和外周血管设备市场还为您提供每个国家/地区特定行业介入心脏病学和外周血管设备销售增长的详细市场分析、介入心脏病学和外周血管设备发展的影响以及监管环境的变化及其对介入心脏病学和外周血管设备市场的支持。数据适用于 2019 年至 2021 年的历史时期。
竞争格局和北美介入心脏病学和外周血管设备市场份额分析
北美介入心脏病学和外周血管设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对介入心脏病学和外周血管设备市场的关注有关。
提供介入心脏病学和外周血管设备的一些主要公司包括美敦力、BD、Cordis、雅培、波士顿科学公司、库克、心血管系统公司、AngioDynamics、爱德华生命科学公司、Biosensors International Group, Ltd.、OrbusNeich Medical Company Limited、Merit Medical Systems、Terumo Medical Corporation、B. Braun Melsungen AG、微创医疗科学公司、乐普医疗技术（北京）有限公司和荷兰皇家飞利浦公司等。
DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。
市场参与者的战略举措以及北美介入心脏病学和外周血管设备的新技术进步正在弥补慢性伤口治疗的空白。
例如，
- 2022年1月，OrbusNeich Medical Co. Ltd.宣布公司推出新产品“Scoreflex NC”，并获得美国食品药品监督管理局（FDA）的上市前批准（PMA）。该产品是一种导管，旨在用作冠状动脉狭窄部位的扩张导管，从而扩大了其产品市场。
市场参与者的合作、合资和其他策略正在增强公司在介入心脏病学和外周血管设备市场中的市场，这也为组织改善其在北美介入心脏病学和外周血管设备市场的产品供应提供了好处。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT SEGMENT LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL
4.2 PORTER'S FIVE FORCES MODEL
5 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 THE RISE IN PREVALENCE OF CHRONIC DISEASES, SUCH AS CORONARY ARTERY DISEASE, ISCHEMIC HEART DISEASE AND VASCULAR DISEASES
6.1.2 AWARENESS AMONG THE POPULATION ABOUT THE TREATMENT AND USE OF THE DEVICES
6.1.3 TECHNOLOGICAL ADVANCEMENTS IN THE CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES
6.1.4 FAVORABLE REIMBURSEMENT POLICIES
6.1.5 INCREASED INTEREST FOR MINIMALLY INVASIVE PROCEDURES
6.2 RESTRAINTS
6.2.1 RISE IN COST OF THE CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES
6.2.2 RISKS OBSERVED WHILE USING INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES
6.2.3 RISE IN PRODUCT RECALL
6.2.4 AVAILABILITY OF ALTERNATE TREATMENTS
6.3 OPPORTUNITIES
6.3.1 GROWING GERIATRIC POPULATION
6.3.2 RISING HEALTHCARE EXPENDITURE
6.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS
6.3.4 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES
6.4 CHALLENGES
6.4.1 STRINGENT RULES & REGULATIONS
6.4.2 LACK OF HOSPITAL INFRASTRUCTURE
7 IMPACT OF COVID-19 PANDEMIC ON THE MARKET
7.1 PRICE IMPACT
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY CHAIN
7.4 STRATEGIC DECISIONS FOR MANUFACTURERS/ SERVICE PROVIDERS
7.5 CONCLUSION
8 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 ANGIOPLASTY BALLOONS
8.2.1 OLD/NORMAL BALLOONS
8.2.2 DRUG ELUTING BALLOONS
8.2.3 CUTTING AND SCORING BALLOONS
8.3 STENT
8.3.1 ANGIOPLASTY STENTS
8.3.2 CORONARY STENTS
8.3.2.1 BARE-METAL STENTS
8.3.2.2 DRUG-ELUTING STENTS (DES)
8.3.2.3 BIO ABSORBABLE STENTS
8.3.3 PERIPHERAL STENTS
8.3.4 OTHERS
8.4 CATHETERS
8.4.1 ANGIOGRAPHY CATHETERS
8.4.2 GUIDING CATHETERS
8.4.3 OTHERS
8.5 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS
8.5.1 ABDOMINAL AORTIC ANEURYSM
8.5.2 THORACIC AORTIC ANEURYSM
8.6 INFERIOR VENA CAVA (IVC) FILTERS
8.6.1 RETRIEVABLE FILTERS
8.6.2 PERMANENT FILTERS
8.7 PLAQUE MODIFICATION DEVICES
8.7.1 THROMBECTOMY DEVICES
8.7.2 ATHERECTOMY DEVICES
8.8 HEMODYNAMIC FLOW ALTERATION DEVICES
8.8.1 EMBOLIC PROTECTION DEVICES
8.8.2 CHRONIC TOTAL OCCLUSION DEVICES
8.9 OTHERS AND ACCESSORIES
8.9.1 GUIDEWIRES
8.9.2 INTRODUCER SHEATHS
8.9.3 BALLOON INFLATION DEVICES
8.9.4 VASCULAR CLOSURE DEVICES
8.9.5 OTHERS
9 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE
9.1 OVERVIEW
9.2 CONVENTIONAL
9.2.1 STENTS
9.2.2 CATHETERS
9.2.3 GUIDEWIRES
9.2.4 VASCULAR CLOSURE DEVICES (VCD)
9.2.5 OTHERS
9.3 ADVANCED
9.3.1 BALLOON CATHETERS
9.3.2 STENT GRAFTS
10 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE
10.1 OVERVIEW
10.2 PERIPHERAL ANGIOPLASTY
10.2.1 ANGIOPLASTY BALLOONS
10.2.2 STENT
10.2.3 CATHETERS
10.2.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS
10.2.5 INFERIOR VENA CAVA (IVC) FILTERS
10.2.6 PLAQUE MODIFICATION DEVICES
10.2.7 HEMODYNAMIC FLOW ALTERATION DEVICES
10.2.8 OTHERS AND ACCESSORIES
10.3 ILIAC INTERVENTION
10.3.1 ANGIOPLASTY BALLOONS
10.3.2 STENT
10.3.3 CATHETERS
10.3.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS
10.3.5 INFERIOR VENA CAVA (IVC) FILTERS
10.3.6 PLAQUE MODIFICATION DEVICES
10.3.7 HEMODYNAMIC FLOW ALTERATION DEVICES
10.3.8 OTHERS AND ACCESSORIES
10.4 TIBIAL (BELOW-THE-KNEE) INTERVENTIONS
10.4.1 ANGIOPLASTY BALLOONS
10.4.2 STENT
10.4.3 CATHETERS
10.4.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS
10.4.5 INFERIOR VENA CAVA (IVC) FILTERS
10.4.6 PLAQUE MODIFICATION DEVICES
10.4.7 HEMODYNAMIC FLOW ALTERATION DEVICES
10.4.8 OTHERS AND ACCESSORIES
10.5 ARTERIAL THROMBECTOMY
10.5.1 ANGIOPLASTY BALLOONS
10.5.2 STENT
10.5.3 CATHETERS
10.5.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS
10.5.5 INFERIOR VENA CAVA (IVC) FILTERS
10.5.6 PLAQUE MODIFICATION DEVICES
10.5.7 HEMODYNAMIC FLOW ALTERATION DEVICES
10.5.8 OTHERS AND ACCESSORIES
10.6 PERIPHERAL ATHERECTOMY
10.6.1 ANGIOPLASTY BALLOONS
10.6.2 STENT
10.6.3 CATHETERS
10.6.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS
10.6.5 INFERIOR VENA CAVA (IVC) FILTERS
10.6.6 PLAQUE MODIFICATION DEVICES
10.6.7 HEMODYNAMIC FLOW ALTERATION DEVICES
10.6.8 OTHERS AND ACCESSORIES
10.7 FEMOROPOPLITEAL INTERVENTIONS
10.7.1 ANGIOPLASTY BALLOONS
10.7.2 STENT
10.7.3 CATHETERS
10.7.4 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS
10.7.5 INFERIOR VENA CAVA (IVC) FILTERS
10.7.6 PLAQUE MODIFICATION DEVICES
10.7.7 HEMODYNAMIC FLOW ALTERATION DEVICES
10.7.8 OTHERS AND ACCESSORIES
11 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION
11.1 OVERVIEW
11.2 PERIPHERAL ARTERIAL DISEASE
11.2.1 ATHEROSCLEROSIS
11.2.2 ABDOMINAL AORTIC ANEURYSM
11.2.3 LOWER EXTREMITY PERIPHERAL ARTERIAL DISEASE
11.2.4 SUPRA-INGUINAL ARTERIAL DISEASE
11.2.5 INFRA-INGUINAL ARTERIAL DISEASE
11.2.6 INFRA-POPLITEAL DISEASE
11.2.7 UPPER EXTREMITY OCCLUSIVE DISEASE
11.2.8 CAROTID ARTERY DISEASE
11.2.9 OTHERS
11.3 CORONARY INTERVENTION
11.3.1 ISCHEMIC HEART DISEASE
11.3.2 THORACIC AORTIC ANEURYSM
11.3.3 VALVE DISEASE
11.3.4 PERCUTANEOUS VALVE REPAIR OR REPLACEMENT
11.3.5 CONGENITAL HEART ABNORMALITIES
11.3.6 OTHERS
12 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP
12.1 OVERVIEW
12.2 GERIATRIC
12.3 ADULTS
12.4 PEDIATRIC
13 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.2.1 PRIVATE
13.2.2 PUBLIC
13.3 AMBULATORY SURGICAL CENTERS
13.4 NURSING FACILITIES
13.5 CLINICS
13.6 OTHERS
14 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 THIRD PARTY DISTRIBUTORS
14.3 DIRECT TENDER
14.4 OTHERS
15 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY GEOGRAPHY
15.1 NORTH AMERICA
15.1.1 U.S.
15.1.2 CANADA
15.1.3 MEXICO
16 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 BOSTON SCIENTIFIC CORPORATION
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENT
18.1.6 ACQUSITION
18.2 CORDIS.
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENTS
18.2.6 PRODUCT LAUNCHES
18.3 ABBOTT
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENTS
18.3.6 PRODUCT LAUNCHES
18.4 BD (2021)
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 COMPANY SHARE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENT
18.5 TERUMO CORPORATION
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENTS
18.5.6 PARTNERSHIP
18.5.7 PRODUCT LAUNCH
18.6 ANGIODYNAMICS.(2021)
18.6.1 COMPANY SNAPSHOT
18.6.2 REVENUE ANALYSIS
18.6.3 PRODUCT PORTFOLIO
18.6.4 RECENT DEVELOPMENTS
18.7 B. BRAUN MELSUNGEN AG (2021)
18.7.1 COMPANY SNAPSHOT
18.7.2 REVENUE ANALYSIS
18.7.3 PRODUCT PORTFOLIO
18.7.4 RECENT DEVELOPMENTS
18.8 BIOSENSORS INTERNATIONAL GROUP, LTD.
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENT
18.9 CARDIOVASCULAR SYSTEMS, INC. (2021)
18.9.1 COMPANY SNAPSHOT
18.9.2 REVENUE ANALYSIS
18.9.3 PRODUCT PORTFOLIO
18.9.4 RECENT DEVELOPMENTS
18.1 COOK
18.10.1 COMPANY SNAPSHOT
18.10.2 PRODUCT PORTFOLIO
18.10.3 RECENT DEVELOPMENTS
18.10.4 EXPANSION
18.10.5 PRODUCT LAUNCHES
18.11 EDWARDS LIFESCIENCES CORPORATION
18.11.1 COMPANY SNAPSHOT
18.11.2 REVENUE ANALYSIS
18.11.3 PRODUCT PORTFOLIO
18.11.4 RECENT DEVELOPMENTS
18.12 KONINKLIJKE PHILIPS N.V.
18.12.1 COMPANY SNAPSHOT
18.12.2 REVENUE ANALYSIS
18.12.3 PRODUCT PORTFOLIO
18.12.4 RECENT DEVELOPMENTS
18.12.5 PRODUCT UPDATES
18.13 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. (2021)
18.13.1 COMPANY SNAPSHOT
18.13.2 REVENUE ANALYSIS
18.13.3 PRODUCT PORTFOLIO
18.13.4 RECENT DEVELOPMENT
18.14 MEDTRONIC
18.14.1 COMPANY SNAPSHOT
18.14.2 REVENUE ANALYSIS
18.14.3 PRODUCT PORTFOLIO
18.14.4 RECENT DEVELOPMENTS
18.14.5 COLLABORATION
18.14.6 PRODUCT LAUNCH
18.15 MERIT MEDICAL SYSTEM
18.15.1 COMPANY SNAPSHOT
18.15.2 REVENUE ANALYSIS
18.15.3 PRODUCT PORTFOLIO
18.15.4 RECENT DEVELOPMENTS
18.16 MICROPORT SCIENTIFIC CORPORATION.
18.16.1 COMPANY SNAPSHOT
18.16.2 REVENUE ANALYSIS
18.16.3 PRODUCT PORTFOLIO
18.16.4 RECENT DEVELOPMENTS
18.16.4.1 PRODUCT APPROVALS
18.17 ORBUSNEICH MEDICAL COMPANY LIMITED
18.17.1 COMPANY SNAPSHOT
18.17.2 PRODUCT PORTFOLIO
18.17.3 RECENT DEVELOPMENT
18.17.4 PRODUCT LAUNCH
18.18 SMT
18.18.1 COMPANY SNAPSHOT
18.18.2 PRODUCT PORTFOLIO
18.18.3 RECENT DEVELOPMENTS
18.19 TELEFLEX INCORPORATED.
18.19.1 COMPANY SNAPSHOT
18.19.2 REVENUE ANALYSIS
18.19.3 PRODUCT PORTFOLIO
18.19.4 RECENT DEVELOPMENTS
18.19.5 ACQUISITIONS
18.2 W. L. GORE & ASSOCIATES, INC.
18.20.1 COMPANY SNAPSHOT
18.20.2 PRODUCT PORTFOLIO
18.20.3 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
表格列表
TABLE 1 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 2 NORTH AMERICA ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 NORTH AMERICA ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 4 NORTH AMERICA STENT IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 NORTH AMERICA STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 6 NORTH AMERICA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 7 NORTH AMERICA CATHETERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 NORTH AMERICA CATHETERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 9 NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 10 NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 11 NORTH AMERICA INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 NORTH AMERICA INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 13 NORTH AMERICA PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 NORTH AMERICA PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 15 NORTH AMERICA HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 NORTH AMERICA HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 17 NORTH AMERICA OTHER AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 NORTH AMERICA OTHER AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 19 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 20 NORTH AMERICA CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 NORTH AMERICA CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 22 NORTH AMERICA ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 NORTH AMERICA ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 24 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 25 NORTH AMERICA PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 26 NORTH AMERICA PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 27 NORTH AMERICA ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 NORTH AMERICA ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 29 NORTH AMERICA TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 NORTH AMERICA TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 31 NORTH AMERICA ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 32 NORTH AMERICA ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 33 NORTH AMERICA PERIPHERAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 NORTH AMERICA PERIPHERAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 35 NORTH AMERICA FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 NORTH AMERICA FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 37 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 38 NORTH AMERICA PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 39 NORTH AMERICA PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 40 NORTH AMERICA CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 NORTH AMERICA CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 42 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 43 NORTH AMERICA GERIATRIC IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 44 NORTH AMERICA ADULTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 45 NORTH AMERICA PEDIATRIC IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 46 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 47 NORTH AMERICA HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 48 NORTH AMERICA HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 49 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 50 NORTH AMERICA NURSING FACILITIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 51 NORTH AMERICA CLINICS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 52 NORTH AMERICA OTHERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 53 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 54 NORTH AMERICA THIRD PARTY DISTRIBUTORS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 55 NORTH AMERICA DIRECT TENDER IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 56 NORTH AMERICA OTHERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 57 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 58 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 59 NORTH AMERICA ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 60 NORTH AMERICA STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 61 NORTH AMERICA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 62 NORTH AMERICA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 63 NORTH AMERICA ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 64 NORTH AMERICA INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 65 NORTH AMERICA PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 66 NORTH AMERICA HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 67 NORTH AMERICA OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 68 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 69 NORTH AMERICA CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 70 NORTH AMERICA ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 71 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 72 NORTH AMERICA ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 73 NORTH AMERICA FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 74 NORTH AMERICA TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 75 NORTH AMERICA PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 76 NORTH AMERICA ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 77 NORTH AMERICA PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 78 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 79 NORTH AMERICA PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 80 NORTH AMERICA CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 81 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 82 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 83 NORTH AMERICA HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 84 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 85 U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 86 U.S. ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 87 U.S. STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 88 U.S. CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 89 U.S. CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 90 U.S. ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 91 U.S. INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 92 U.S. PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 93 U.S. HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 94 U.S. OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 95 U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 96 U.S. CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 97 U.S. ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 98 U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 99 U.S. ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 100 U.S. FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 101 U.S. TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 102 U.S. PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 103 U.S. ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 104 U.S. PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 105 U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 106 U.S. PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 107 U.S. CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 108 U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 109 U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 110 U.S. HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 111 U.S. INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 112 CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 113 CANADA ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 114 CANADA STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 115 CANADA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 116 CANADA CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 117 CANADA ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 118 CANADA INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 119 CANADA PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 120 CANADA HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 121 CANADA OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 122 CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 123 CANADA CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 124 CANADA ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 125 CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 126 CANADA ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 127 CANADA FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 128 CANADA TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 129 CANADA PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 130 CANADA ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 131 CANADA PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 132 CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 133 CANADA PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 134 CANADA CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 135 CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 136 CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 137 CANADA HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 138 CANADA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 139 MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 140 MEXICO ANGIOPLASTY BALLOONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 141 MEXICO STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 142 MEXICO CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 143 MEXICO CORONARY STENTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 144 MEXICO ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 145 MEXICO INFERIOR VENA CAVA (IVC) FILTERS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 146 MEXICO PLAQUE MODIFICATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 147 MEXICO HEMODYNAMIC FLOW ALTERATION DEVICES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 148 MEXICO OTHERS AND ACCESSORIES IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 149 MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 150 MEXICO CONVENTIONAL IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 151 MEXICO ADVANCED IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 152 MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 153 MEXICO ILIAC INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 154 MEXICO FEMOROPOPLITEAL INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 155 MEXICO TIBIAL (BELOW-THE-KNEE) INTERVENTIONS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 156 MEXICO PERIPHERAL ANGIOPLASTY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 157 MEXICO ARTERIAL THROMBECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 158 MEXICO PERIPHERAL ATHERECTOMY IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY PROCEDURE, 2020-2029 (USD MILLION)
TABLE 159 MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 160 MEXICO PERIPHERAL ARTERIAL DISEASE IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 161 MEXICO CORONARY INTERVENTION IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY INDICATION, 2020-2029 (USD MILLION)
TABLE 162 MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)
TABLE 163 MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 164 MEXICO HOSPITALS IN INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 165 MEXICO INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET : SEGMENTATION
FIGURE 2 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: DBMR POSITION GRID
FIGURE 8 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: END USER COVERAGE GRID
FIGURE 10 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: SEGMENTATION
FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 INCREASED PREVALENCE OF CHRONIC CARDIAC DISEASES, RISE IN TECHNOLOGICAL ADVANCEMENTS IN NON-INVASIVE SURGERIES AND PRODUCT APPPROVALS IS EXPECTED TO DRIVE NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET FROM 2022 TO 2029
FIGURE 13 PRODUCT SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET FROM 2022 & 2029
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET
FIGURE 15 NORTH AMERICA PREVALENCE AND DISABILITY RATE OF ISCHEMIC HEART DISEASE (IHD) IN 2021
FIGURE 16 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT, 2021
FIGURE 17 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT, 2022-2029 (USD MILLION)
FIGURE 18 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT, CAGR (2022-2029)
FIGURE 19 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 20 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY TYPE, 2021
FIGURE 21 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY TYPE, 2022-2029 (USD MILLION)
FIGURE 22 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY TYPE, CAGR (2022-2029)
FIGURE 23 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY TYPE, LIFELINE CURVE
FIGURE 24 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PROCEDURE, 2021
FIGURE 25 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PROCEDURE, 2022-2029 (USD MILLION)
FIGURE 26 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PROCEDURE, CAGR (2022-2029)
FIGURE 27 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PROCEDURE, LIFELINE CURVE
FIGURE 28 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY INDICATION, 2021
FIGURE 29 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY INDICATION, 2022-2029 (USD MILLION)
FIGURE 30 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY INDICATION, CAGR (2022-2029)
FIGURE 31 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY INDICATION, LIFELINE CURVE
FIGURE 32 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY AGE GROUP, 2021
FIGURE 33 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY AGE GROUP, 2022-2029 (USD MILLION)
FIGURE 34 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY AGE GROUP, CAGR (2022-2029)
FIGURE 35 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 36 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY END USER, 2021
FIGURE 37 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 38 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY END USER, CAGR (2022-2029)
FIGURE 39 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 40 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 41 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 42 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 43 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 44 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: SNAPSHOT (2021)
FIGURE 45 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY COUNTRY (2021)
FIGURE 46 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 47 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 48 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT (2021-2029)
FIGURE 49 NORTH AMERICA INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: COMPANY SHARE 2021 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
